在瘤代谢重编程和瘤微环境重塑中的LncRNAs
Jianhang Jiao1, Yangzhi Zhao2, Qimei Li3
1Department of Orthopedics, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in immunology
|November 14, 2024
概括
长非编码RNAs (lncRNAs) 重编程瘤代谢,影响瘤微环境 (TME). 这些lncRNA具有作为癌症治疗标和预后生物标记物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 通常具有免疫抑制作用,促进癌症的进展.
- 癌细胞经历代谢重编程以生存和增殖.
- 代谢竞争和瘤代谢物进一步抑制TME内的免疫反应.
研究的目的:
- 探索瘤代谢重编程的lncRNA介导调节机制.
- 要了解 lncRNAs 如何重塑 TME.
- 评估 lncRNAs 作为抗瘤治疗点和预后生物标志物.
主要方法:
- 文献审查和现有研究的讨论.
- 分析lncRNA与代谢途径和TME组件的相互作用.
- 检查lncRNA在瘤生长,转移,耐药性和免疫抑制中的作用.
主要成果:
- lncRNAs调节瘤代谢中的关键酶,载体和信号通路.
- lncRNA与细胞和非细胞TME组件相互作用.
- lncRNAs涉及促进瘤生长,转移,耐药性和免疫抑制.
结论:
- lncRNAs通过调节瘤代谢重编程来显著重塑TME.
- lncRNAs作为癌症治疗的新型治疗点具有前途.
- lncRNAs可以作为预测瘤预后的有价值的生物标志物.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K


